A future for our children and grandchildren, whose medical care is governed and guided by health and not disease: Safe cell treatments and regenerative therapies that heal and save lives; humane and accessible to everyone. We have dedicated ourselves to the regenerative medicine – ethical, responsible, visionary and passionate!
Kugelmeiers contributes to and provides accessibility to regenerative medicine, believing it to be a potential for future medical therapies that everyone should have access to. We developed as a result of 18 years of research and dedication in the ﬁeld of transplant surgery, cell therapy and developmental biology, a technology and ecosystems allowing us to make an impact on islet, liver and many other cell therapies that rely on 3D spheroids that need a medical quality platform.
Our company was founded in 2015 as a spin-off from the University of Zurich in Switzerland.